Medtronic (MDT) Revenue (2014 - 2026)

Medtronic (MDT) has 13 years of Revenue data on file, last reported at $9.8 billion in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 9.86% year-over-year to $9.8 billion; the trailing twelve-month figure through Apr 2026 stood at $36.4 billion (up 8.43% YoY), and the FY2026 full-year result was $36.4 billion, up 8.43% from the prior year.
• Revenue advanced to $9.8 billion in Q2 2026, from $9.0 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $9.8 billion in Q2 2026 to a low of $7.4 billion in Q3 2022.
• A 5-year average of $8.3 billion and a median of $8.2 billion in 2022 frame the typical range for Revenue.
• Across the five-year window, Revenue dropped 7.71% in 2022 and grew 9.86% in 2026, its largest moves.
• Tracing MDT's Revenue over 5 years: stood at $7.6 billion in 2022, then gained by 5.26% to $8.0 billion in 2023, then gained by 5.25% to $8.4 billion in 2024, then increased by 6.64% to $9.0 billion in 2025, then rose by 9.44% to $9.8 billion in 2026.
• Business Quant data shows MDT's Revenue at $9.8 billion in Q2 2026, $9.0 billion in Q1 2026, and $9.0 billion in Q4 2025.